Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

Immunoglobulins, normal human, for intravascular [Power / Sample Size]

posted by Yura – Belarus, 2016-01-13 07:51 (3819 d 20:45 ago) – Posting: # 15817
Views: 7,987

Hi
How to calculate the sample size for the non-comparative trials for biosimilar, or what are the approaches to solving this problem?
Aim - assessment of treatment effectiveness (improvement in symptoms).
Best regards,
Yura

Complete thread:

Immunoglobulins, normal human, for intravascularYura 2016-01-13 06:51
- Immunoglobulins, normal human, for intravascular BE-proff 2016-01-14 11:15
- Immunoglobulins, normal human, for intravascular Dr_Dan 2016-01-14 13:37
- Immunoglobulins, normal human, for intravascular Yura 2016-01-15 08:53
  - Immunoglobulins, normal human, for intravascular Dr_Dan 2016-01-18 17:17

Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
380 visitors (0 registered, 380 guests [including 19 identified bots]).
Forum time: 05:36 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas. Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz